The drug, sold as Rezdiffra, was first approved in the United States in March last year. The disease known as non-alcoholic ...

Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine tumors, regardless of tumor site, grade or previous non-somato ...

Positive recommendation based on resmetirom’s favorable profile including positive results from the pivotal Phase 3 MAESTRO-NASH trialEuropean Commission decision expected in August 2025; if approved, ...

An Irish woman who headed Ireland’s medicine’s watchdog has been appointed to take over as Executive Director of the European ...

Lorraine Nolan has been appointed to the high-profile role as head of the EU’s drug agency. She was appointed executive director of the European Union Drugs Agency after receiving a two-thirds ...

Archie Ennis suffers from Duchenne muscular dystrophy and is in desperate need of medication to help his condition ...

EU drug agency report said semi-synthetic cannabinoids have 'spread rapidly' in recent years, with one of these substances, ...

The EU's sweeping new rules on the regulation of medicines has been one of the most bitterly contested pieces of legislation in recent times, with fierce lobbying by the pharma sector, writes Europe ...

EU member states have adopted a controversial set of new measures governing the regulation of medicines at European level, following two years of deadlock and "unprecedented" lobbying by the pharma ...